| Dr Jessica Wilczek, DPM | |
|
10 Rotary Ave, Binghamton, NY 13905-4181 | |
| (315) 368-4206 | |
| Not Available |
| Full Name | Dr Jessica Wilczek |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 9 Years |
| Location | 10 Rotary Ave, Binghamton, New York |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609236082 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | P97785 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Instride Foot And Ankle Specialists, Pllc | 7012168271 | 55 |
News Archive
Encision Inc., a medical device company owning patented surgical technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced that it has launched its AEM EndoShield Burn Protection System ("EndoShield").
The Patient-Centered Outcomes Research Institute, an independent board established by the health law, will meet this week to set priorities for "comparative effectiveness research." In other news related to the health law, the News Hour reports on how the overahul has impacted pediatric cancer patients and the New York Times reports on the law's provisions related to screening kids for obesity and providing them counseling.
Javelin Pharmaceuticals, Inc., today announced the successful completion of the tender offer by Discus Acquisition Corporation, a wholly owned subsidiary of Hospira, Inc., to purchase all outstanding shares of the common stock of Javelin.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced it has completed its previously announced acquisition of Athena Diagnostics, an esoteric laboratory specializing in genetic testing for neurological disorders, from Thermo Fisher Scientific.
Ambry Genetics announced today the launch of BRCA1 and BRCA2 analysis as part of their comprehensive cancer-testing menu. Two genes will be offered as a stand alone test comprising of full gene sequencing and deletion/duplication analyses in addition to being incorporated as part of multiple hereditary cancer panels that test cancer susceptibility genes using next-generation sequencing technology.
› Verified 3 days ago
| Provider Name | Instride Foot & Ankle Specialists, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1457601601 PECOS PAC ID: 7012168271 Enrollment ID: O20121115000501 |
News Archive
Encision Inc., a medical device company owning patented surgical technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced that it has launched its AEM EndoShield Burn Protection System ("EndoShield").
The Patient-Centered Outcomes Research Institute, an independent board established by the health law, will meet this week to set priorities for "comparative effectiveness research." In other news related to the health law, the News Hour reports on how the overahul has impacted pediatric cancer patients and the New York Times reports on the law's provisions related to screening kids for obesity and providing them counseling.
Javelin Pharmaceuticals, Inc., today announced the successful completion of the tender offer by Discus Acquisition Corporation, a wholly owned subsidiary of Hospira, Inc., to purchase all outstanding shares of the common stock of Javelin.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced it has completed its previously announced acquisition of Athena Diagnostics, an esoteric laboratory specializing in genetic testing for neurological disorders, from Thermo Fisher Scientific.
Ambry Genetics announced today the launch of BRCA1 and BRCA2 analysis as part of their comprehensive cancer-testing menu. Two genes will be offered as a stand alone test comprising of full gene sequencing and deletion/duplication analyses in addition to being incorporated as part of multiple hereditary cancer panels that test cancer susceptibility genes using next-generation sequencing technology.
› Verified 3 days ago
| Provider Name | King Podiatry And Associates Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1366631087 PECOS PAC ID: 1254647837 Enrollment ID: O20151008001285 |
News Archive
Encision Inc., a medical device company owning patented surgical technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced that it has launched its AEM EndoShield Burn Protection System ("EndoShield").
The Patient-Centered Outcomes Research Institute, an independent board established by the health law, will meet this week to set priorities for "comparative effectiveness research." In other news related to the health law, the News Hour reports on how the overahul has impacted pediatric cancer patients and the New York Times reports on the law's provisions related to screening kids for obesity and providing them counseling.
Javelin Pharmaceuticals, Inc., today announced the successful completion of the tender offer by Discus Acquisition Corporation, a wholly owned subsidiary of Hospira, Inc., to purchase all outstanding shares of the common stock of Javelin.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced it has completed its previously announced acquisition of Athena Diagnostics, an esoteric laboratory specializing in genetic testing for neurological disorders, from Thermo Fisher Scientific.
Ambry Genetics announced today the launch of BRCA1 and BRCA2 analysis as part of their comprehensive cancer-testing menu. Two genes will be offered as a stand alone test comprising of full gene sequencing and deletion/duplication analyses in addition to being incorporated as part of multiple hereditary cancer panels that test cancer susceptibility genes using next-generation sequencing technology.
› Verified 3 days ago
| Provider Name | Gooden Mobile Pod Nc Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1073003752 PECOS PAC ID: 2769738715 Enrollment ID: O20180703003175 |
News Archive
Encision Inc., a medical device company owning patented surgical technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced that it has launched its AEM EndoShield Burn Protection System ("EndoShield").
The Patient-Centered Outcomes Research Institute, an independent board established by the health law, will meet this week to set priorities for "comparative effectiveness research." In other news related to the health law, the News Hour reports on how the overahul has impacted pediatric cancer patients and the New York Times reports on the law's provisions related to screening kids for obesity and providing them counseling.
Javelin Pharmaceuticals, Inc., today announced the successful completion of the tender offer by Discus Acquisition Corporation, a wholly owned subsidiary of Hospira, Inc., to purchase all outstanding shares of the common stock of Javelin.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced it has completed its previously announced acquisition of Athena Diagnostics, an esoteric laboratory specializing in genetic testing for neurological disorders, from Thermo Fisher Scientific.
Ambry Genetics announced today the launch of BRCA1 and BRCA2 analysis as part of their comprehensive cancer-testing menu. Two genes will be offered as a stand alone test comprising of full gene sequencing and deletion/duplication analyses in addition to being incorporated as part of multiple hereditary cancer panels that test cancer susceptibility genes using next-generation sequencing technology.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jessica Wilczek, DPM 10 Rotary Ave, Binghamton, NY 13905-4181 Ph: (315) 368-4206 | Dr Jessica Wilczek, DPM 10 Rotary Ave, Binghamton, NY 13905-4181 Ph: (315) 368-4206 |
News Archive
Encision Inc., a medical device company owning patented surgical technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced that it has launched its AEM EndoShield Burn Protection System ("EndoShield").
The Patient-Centered Outcomes Research Institute, an independent board established by the health law, will meet this week to set priorities for "comparative effectiveness research." In other news related to the health law, the News Hour reports on how the overahul has impacted pediatric cancer patients and the New York Times reports on the law's provisions related to screening kids for obesity and providing them counseling.
Javelin Pharmaceuticals, Inc., today announced the successful completion of the tender offer by Discus Acquisition Corporation, a wholly owned subsidiary of Hospira, Inc., to purchase all outstanding shares of the common stock of Javelin.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced it has completed its previously announced acquisition of Athena Diagnostics, an esoteric laboratory specializing in genetic testing for neurological disorders, from Thermo Fisher Scientific.
Ambry Genetics announced today the launch of BRCA1 and BRCA2 analysis as part of their comprehensive cancer-testing menu. Two genes will be offered as a stand alone test comprising of full gene sequencing and deletion/duplication analyses in addition to being incorporated as part of multiple hereditary cancer panels that test cancer susceptibility genes using next-generation sequencing technology.
› Verified 3 days ago
Dr. Joseph William Romani, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 169 Riverside Dr, Binghamton, NY 13905 Phone: 607-798-5726 | |
Joan Adler, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 65 Pennsylvania Ave, Suite 200, Binghamton, NY 13903 Phone: 607-772-8772 Fax: 607-772-8796 | |
Binghamton Podiatry Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 38 Front St, # 2b, Binghamton, NY 13905 Phone: 607-724-1263 Fax: 607-724-1263 | |
James Edward Mcnerney, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 65 Pennsylvania Ave, Suite 200, Binghamton, NY 13903 Phone: 607-772-8772 Fax: 607-772-8796 | |
Shari L Nichols, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 65 Pennsylvania Ave, Suite 200, Binghamton, NY 13903 Phone: 607-772-8772 Fax: 607-772-8796 | |
Robert C Philips, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 134 Riverside Dr, Binghamton, NY 13905 Phone: 607-723-9018 Fax: 607-723-0715 | |
Dr. John Cornelius Donovan, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 161 Riverside Dr, Suite M08, Binghamton, NY 13905 Phone: 607-770-8000 Fax: 607-770-9755 |